Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)

Introduction Bilateral prophylactic mastectomy (BPM) in women with a high risk of developing breast cancer has shown to provide the greatest risk reduction. Many surgical guidelines recommend the removal of the pectoral fascia (PF) in mastectomies; however, there is no evidence to support this state...

Full description

Saved in:
Bibliographic Details
Main Authors: Cornelis Verhoef, Linetta B Koppert, Marloes E Clarijs, Laurentine S E van Egdom, Dalibor Vasilic, T. van Dalen, C. de Betue, J. Rothbarth, E.V.E. Madsen, L.M. Beelen, M.A.M. Mureau, E.M.L. Corten, A.J.M. Luijsterburg, M.J. Hop, H.M. Zuijdendorp, N.A.S. Posch, C.M.C.A. van Laarhoven, M. de Kraker
Format: Article
Language:English
Published: BMJ Publishing Group 2023-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/2/e066728.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825208457187295232
author Cornelis Verhoef
Linetta B Koppert
Marloes E Clarijs
Laurentine S E van Egdom
Dalibor Vasilic
T. van Dalen
C. de Betue
J. Rothbarth
E.V.E. Madsen
L.M. Beelen
M.A.M. Mureau
E.M.L. Corten
A.J.M. Luijsterburg
M.J. Hop
H.M. Zuijdendorp
N.A.S. Posch
C.M.C.A. van Laarhoven
M. de Kraker
author_facet Cornelis Verhoef
Linetta B Koppert
Marloes E Clarijs
Laurentine S E van Egdom
Dalibor Vasilic
T. van Dalen
C. de Betue
J. Rothbarth
E.V.E. Madsen
L.M. Beelen
M.A.M. Mureau
E.M.L. Corten
A.J.M. Luijsterburg
M.J. Hop
H.M. Zuijdendorp
N.A.S. Posch
C.M.C.A. van Laarhoven
M. de Kraker
collection DOAJ
description Introduction Bilateral prophylactic mastectomy (BPM) in women with a high risk of developing breast cancer has shown to provide the greatest risk reduction. Many surgical guidelines recommend the removal of the pectoral fascia (PF) in mastectomies; however, there is no evidence to support this statement. Reported wound-related complications following mastectomy include seroma, flap necrosis, infection and haematoma. Seroma causes discomfort and may delay the reconstructive procedures. Whether removal or preservation of the PF influences drain volume, seroma formation and other postoperative complications following BPM remains unclear. The aim of this study is to assess the impact of removal versus preservation of the PF on drain policy and seroma after BPM.Methods and analysis This is a double blinded, prospective, randomised controlled pilot study with a within-subject design. The inclusion criteria are women >18 years, presenting in the Academic Breast Cancer Centre Rotterdam, who are opting for BPM. Patients with a history or diagnosis of breast cancer are excluded. According to the sample size calculation based on the difference in total drain volume, a number of 21 eligible patients will be included. Randomisation will occur within the patient, which means PF preservation in one breast and PF removal in the contralateral breast. The primary study endpoint is total drainage volume. Secondary study outcomes include time to drain removal, number of needle aspirations, postoperative complications and length of hospital stay.Ethics and dissemination The study is approved by the Erasmus Medical Center Review Board (REC 2020–0431). Results will be presented during international conferences and published in a peer-reviewed academic journal.Trial registration number NCT05391763; clinicaltrials.gov
format Article
id doaj-art-9069d9a303434dc3b390ecc4f3eef1a2
institution Kabale University
issn 2044-6055
language English
publishDate 2023-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-9069d9a303434dc3b390ecc4f3eef1a22025-02-06T22:55:09ZengBMJ Publishing GroupBMJ Open2044-60552023-02-0113210.1136/bmjopen-2022-066728Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS) 0Cornelis Verhoef1Linetta B Koppert2Marloes E Clarijs3Laurentine S E van Egdom4Dalibor Vasilic5T. van DalenC. de BetueJ. RothbarthE.V.E. MadsenL.M. BeelenM.A.M. MureauE.M.L. CortenA.J.M. LuijsterburgM.J. HopH.M. ZuijdendorpN.A.S. PoschC.M.C.A. van LaarhovenM. de Kraker1Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKDepartment of Surgical Oncology, Erasmus MC, Rotterdam, The NetherlandsDepartment of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, The NetherlandsDepartment of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, The NetherlandsDepartment of Plastic and Reconstructive Surgery, Erasmus Medical Center, Rotterdam, Zuid-Holland, The NetherlandsDepartment of Plastic and Reconstructive Surgery, Erasmus Medical Center, Rotterdam, Zuid-Holland, The NetherlandsIntroduction Bilateral prophylactic mastectomy (BPM) in women with a high risk of developing breast cancer has shown to provide the greatest risk reduction. Many surgical guidelines recommend the removal of the pectoral fascia (PF) in mastectomies; however, there is no evidence to support this statement. Reported wound-related complications following mastectomy include seroma, flap necrosis, infection and haematoma. Seroma causes discomfort and may delay the reconstructive procedures. Whether removal or preservation of the PF influences drain volume, seroma formation and other postoperative complications following BPM remains unclear. The aim of this study is to assess the impact of removal versus preservation of the PF on drain policy and seroma after BPM.Methods and analysis This is a double blinded, prospective, randomised controlled pilot study with a within-subject design. The inclusion criteria are women >18 years, presenting in the Academic Breast Cancer Centre Rotterdam, who are opting for BPM. Patients with a history or diagnosis of breast cancer are excluded. According to the sample size calculation based on the difference in total drain volume, a number of 21 eligible patients will be included. Randomisation will occur within the patient, which means PF preservation in one breast and PF removal in the contralateral breast. The primary study endpoint is total drainage volume. Secondary study outcomes include time to drain removal, number of needle aspirations, postoperative complications and length of hospital stay.Ethics and dissemination The study is approved by the Erasmus Medical Center Review Board (REC 2020–0431). Results will be presented during international conferences and published in a peer-reviewed academic journal.Trial registration number NCT05391763; clinicaltrials.govhttps://bmjopen.bmj.com/content/13/2/e066728.full
spellingShingle Cornelis Verhoef
Linetta B Koppert
Marloes E Clarijs
Laurentine S E van Egdom
Dalibor Vasilic
T. van Dalen
C. de Betue
J. Rothbarth
E.V.E. Madsen
L.M. Beelen
M.A.M. Mureau
E.M.L. Corten
A.J.M. Luijsterburg
M.J. Hop
H.M. Zuijdendorp
N.A.S. Posch
C.M.C.A. van Laarhoven
M. de Kraker
Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
BMJ Open
title Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
title_full Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
title_fullStr Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
title_full_unstemmed Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
title_short Bilateral prophylactic mastectomy: should we preserve the pectoral fascia? Protocol of a Dutch double blinded, prospective, randomised controlled pilot study with a within-subject design (PROFAS)
title_sort bilateral prophylactic mastectomy should we preserve the pectoral fascia protocol of a dutch double blinded prospective randomised controlled pilot study with a within subject design profas
url https://bmjopen.bmj.com/content/13/2/e066728.full
work_keys_str_mv AT bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT cornelisverhoef bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT linettabkoppert bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT marloeseclarijs bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT laurentinesevanegdom bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT daliborvasilic bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT tvandalen bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT cdebetue bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT jrothbarth bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT evemadsen bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT lmbeelen bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT mammureau bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT emlcorten bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT ajmluijsterburg bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT mjhop bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT hmzuijdendorp bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT nasposch bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT cmcavanlaarhoven bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas
AT mdekraker bilateralprophylacticmastectomyshouldwepreservethepectoralfasciaprotocolofadutchdoubleblindedprospectiverandomisedcontrolledpilotstudywithawithinsubjectdesignprofas